COMMUNIQUÉS West-GlobeNewswire

Radius Health to Present at 2018 RBC Capital Markets Global Healthcare Conference
14/02/2018
WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that Jesper Høiland, President and CEO of the Company, will present a corporate update at the 2018 RBC Capital [...]
Radius Health to Announce Fourth Quarter and Full Year 2017 Financial Results, Host Conference Call and Live Webcast on March 1, 2018
14/02/2018
WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that it will release its fourth quarter and full year 2017 financial results on Thursday, March 1, 2018. The Company [...]
Dynavax to Present at the RBC Capital Markets Global Healthcare Conference
14/02/2018
BERKELEY, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) announced today that Eddie Gray, Dynavax’s chief executive officer, will participate in a fireside chat at the 2018 [...]
Athenex Announces Early Completion of Patients Enrollment for Two Phase III Clinical Studies of KX2-391 Ointment for Actinic Keratosis
14/02/2018
BUFFALO, N.Y., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as Chief Operating Officer
14/02/2018
RA’ANANA, Israel and NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Sona Jasani, MD is Honored by the American Health Council for “Best in Medicine”
14/02/2018
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to name Sona Jasani, MD as one of “America’s Best Doctors” for her unparalleled professional dedication and extraordinary contributions [...]
HempAmericana Fully Executes Contract To Acquire Local Farm for Seed Production
14/02/2018
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce the potential acquisition of a ten acres farm in Maine. The Company [...]
Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures
14/02/2018
DANVERS, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq: ABMD ), a leading provider of breakthrough heart support and recovery technologies, today announced that it has received an expanded U.S. Food and [...]
Inovalon Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
14/02/2018
BOWIE, Md., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
Alimera Sciences to Report Fourth Quarter and Full Year 2017 Results on February 28, 2018
14/02/2018
ATLANTA, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ: ALIM ), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it will release its [...]
Intercept Pharmaceuticals Reports Full Year and Fourth Quarter 2017 Financial Results and Provides Business Update
14/02/2018
Worldwide Net Ocaliva ® (obeticholic acid or OCA) full year 2017 net sales of $129.2 million, fourth quarter 2017 sales of $37.3 million U.S. Prescribing Information for Ocaliva ® updated to reinforce appropriate dosing [...]
Shire plc : Final Results
14/02/2018
Shire reports 8% pro forma product sales and strong earnings growth resulting in record operating cash flow for full year 2017 Strong growth driven by Immunology, recently launched products, and global expansion [...]
Agios Reports Fourth Quarter and Full Year 2017 Financial Results
14/02/2018
– All 2017 Key Milestones Achieved, Including First U.S. Product Approval from Agios’ Discovery Platform and NDA Submission for Second Product Candidate, Ivosidenib, for IDH1m R/R AML – – 2018 Priorities Focus on [...]
Midatech Pharma Plc: Trading update
14/02/2018
14 February 2018 Midatech Pharma PLC ("Midatech", "Company" or "Group") Trading update Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising [...]
AxoGen, Inc. to Report Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call on February 28, 2018
14/02/2018
ALACHUA, Fla., Feb. 14, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve injuries, today announced that [...]
G1 Therapeutics to Report Fourth Quarter and Full-Year 2017 Financial Results on February 21, 2018
14/02/2018
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that fourth quarter and full-year 2017 financial results will be [...]
Microbix Reports Record First Quarter Sales
14/02/2018
TORONTO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX ) (Microbix®), an innovator of biological products and technologies, reports financial results for its first quarter of fiscal 2018, the [...]
Hydropothecary signs letter of intent to supply Québec market
14/02/2018
Hydropothecary signs LOI with Société des alcools du Québec for supply of cannabis. Hydropothecary will supply 20,000 kg of cannabis for the first year of the adult-use recreational cannabis. The LOI covers the full [...]
Hydropothecary signe une lettre d’intention pour approvisionner le marché québécois
14/02/2018
La Société signe une lettre d’intention avec la Société des alcools du Québec concernant l’approvisionnement en cannabis. Hydropothecary fournira 20 000 kg de produits de cannabis pour la prochaine année. La lettre d’ [...]

Pages